Quality

External Quality Assessment

In order to ensure the quality of the results obtained, GenoMed® participates in external evaluation programs promoted by several international entities, such as:

• EMQN – European Molecular Quality Network
• GenQA – Genomic Quality Assessment, is a member of UK NEQAS Consortium
• UK-NEQAS – United Kingdom National External Quality Assessment Service
• GHEP-ISFG – Spanish and Portuguese Language Group of the International Forensic Genetics Society
• CAP – College of American Pathologists

Guidelines/ Recommendations

The internal quality control procedures implemented are based on guidelines and recommendations issued by prestigious international institutions and reference in their respective areas.
Some examples are:

• EMQN – Best practice guidelines;
• ACMG – Best practice guidelines (NGS);
• ACGS – Practice guidelines for Targeted Next Generation Sequencing Analysis and Interpretation;
• EuroGentest – Standards and Guidelines for clinical Genetics Laboratories – American College of Medical Genetics;
• OECD – Guidelines for quality assurance in molecular genetic testing;
• EuroGentest – Cytogenetic Guidelines and Quality Assurance;
• Association for Clinical Cytogenetics – Professional guidelines for clinical cytogenetics;
• National Comprehensive Cancer Network (NCCN) – Clinical Practice Guidelines in Oncology;
• European LeukemiaNet – Diagnosis and Management of Acute Myeloid Leukemia in adults (Recommendations from an International Expert Panel);
• European LeukemiaNet – Recommendations for the Management of Chronic Myeloid Leukemia (CML).